Nagaraj, Yeshaswini http://orcid.org/0000-0001-9288-9537
Wisselink, Hendrik Joost
Rook, Mieneke
Cai, Jiali
Nagaraj, Sunil Belur
Sidorenkov, Grigory
Veldhuis, Raymond
Oudkerk, Matthijs
Vliegenthart, Rozemarijn
van Ooijen, Peter
Funding for this research was provided by:
interreg
siemens healthineers and the ministry of economic affairs and climate policy, the netherlands
Article History
Received: 29 June 2021
Revised: 3 January 2022
Accepted: 29 January 2022
First Online: 18 February 2022
Declarations
:
: Approved by Institutional Review Board–the Medical Ethical Committee (METc) of the University Medical Center Groningen.
: Written informed consent was obtained from all subjects of the ImaLife and NLST study.
: The details of eligibility criteria for the participants of ImaLife and National Lung Cancer screening (NLST) have been previously described. There was no-overlap of study subjects or cohorts.
: One of the authors has significant statistical expertise.
: Prof. Dr. Rozemarijn Vliegenthart reports an institutional research grant from Siemens Healthineers. There are no other interests to disclose. Rest of the authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.